A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2020

Study Completion Date

January 31, 2021

Conditions
Mitral RegurgitationMitral Valve RegurgitationFunctional Mitral Regurgitation
Interventions
DEVICE

AccuCinch® Ventriculoplasty System

Mitral valve repair due to functional disease

Trial Locations (8)

22527

Medical Care Center Hamburg University Cardiovascular Center, Hamburg

Unknown

Medical University of Vienna, Vienna

University Hospital Freiburg-Bad Krozingen, Bad Krozingen

Immanuel Klinikum Bernau Herzzentrum Brandenburg, Bernau

St.-Johannes-Hospital, Dortmund

Universitätsklinikum Düsseldorf, Düsseldorf

Cardiovascular Center Frankfurt, Frankfurt

Vilnius University Hospital Santaros Klinikos, Vilnius

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ancora Heart, Inc.

INDUSTRY

NCT00800046 - A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study | Biotech Hunter | Biotech Hunter